TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
DrugtestScandinavia AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,801
|
2,334
|
1,739 |
Financial expenses |
0
|
28
|
0 |
Earnings before taxes |
-312
|
-23
|
148 |
EBITDA |
-321
|
4
|
134 |
Total assets |
1,336
|
1,917
|
1,706 |
Current assets |
1,336
|
1,657
|
1,653 |
Current liabilities |
1,231
|
811
|
538 |
Equity capital |
105
|
1,106
|
1,130 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
7.9%
|
57.7%
|
66.2% |
Turnover per employee |
1,400
|
1,167
|
870 |
Profit as a percentage of turnover |
-11.1%
|
-1.0%
|
8.5% |
Return on assets (ROA) |
-23.4%
|
0.3%
|
8.7% |
Current ratio |
108.5%
|
204.3%
|
307.2% |
Return on equity (ROE) |
-297.1%
|
-2.1%
|
13.1% |
Change turnover |
467
|
595
|
-40 |
Change turnover % |
20%
|
34%
|
-2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.